Product image of Moviprep (Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr) supplied by GNH India

Moviprep

Active Ingredient:
Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr
Origin:
EU

Moviprep (Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr)

Polyethylene glycol, the active ingredient in Moviprep, is an osmotic laxative presented as an oral solution for oral use. It is used to cleanse the bowel before colonoscopy or sigmoidoscopy in adult patients.
GNH India supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Norgine Portugal Farmaceutica Unipessoal, Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moviprep is an osmotic laxative indicated for bowel cleansing procedures.

  • Colonoscopy preparation: provides thorough colon cleansing to enable clear endoscopic visualization.
  • Sigmoidoscopy preparation: clears the distal colon and rectum for accurate examination.
  • Diagnostic imaging preparation: cleanses the bowel before procedures such as barium enema to improve image quality.

How It Works

  • Polyethylene glycol creates an osmotic gradient in the intestinal lumen, retaining water and electrolytes. The increased fluid volume softens stool and expands the intestinal contents, stimulating peristalsis and resulting in rapid, complete bowel evacuation required for diagnostic procedures.

Side Effects

Moviprep may cause several adverse reactions, ranging from mild to serious.

Common Side Effects

  • Nausea: mild to moderate feeling of sickness.
  • Abdominal discomfort: cramping or bloating.
  • Diarrhea: frequent loose stools.
  • Electrolyte imbalance: mild changes in sodium or potassium levels.
  • Thirst: increased sensation of needing fluids.
  • Headache: transient mild headache.

Serious or Rare Side Effects

  • Severe dehydration: marked fluid loss requiring medical attention.
  • Electrolyte disturbances: significant hyponatremia or hypokalemia.
  • Allergic reaction: rash, itching, or swelling.
  • Severe abdominal pain: persistent or worsening pain.
  • Syncope: fainting episodes.
  • Renal impairment: worsening kidney function in susceptible individuals.

Precautions & Warnings

Before using Moviprep, consider the following precautions.

  • Renal function: assess kidney status in patients with existing renal disease.
  • Cardiac status: evaluate heart failure patients for fluid overload risk.
  • Electrolyte balance: monitor serum electrolytes in patients on diuretics or with electrolyte disorders.
  • Gastrointestinal obstruction: avoid use in patients with known or suspected bowel obstruction.
  • Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
  • Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Moviprep can interact with other medicines, requiring attention to avoid complications.

Major Interactions (Avoid)

  • Loop diuretics: may exacerbate electrolyte loss.
  • Laxatives containing magnesium: increase risk of severe diarrhea and dehydration.
  • Anticholinergic agents: may reduce efficacy of bowel cleansing.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: monitor blood pressure and renal function.
  • NSAIDs: watch for potential renal impairment.
  • Oral rehydration solutions: adjust electrolyte composition as needed.

Frequently Asked Questions

Moviprep is a polyethylene glycol‑based oral solution used to cleanse the colon before diagnostic procedures such as colonoscopy and sigmoidoscopy. It prepares the bowel by inducing thorough evacuation, allowing clear visualization of the intestinal lining.

Polyethylene glycol acts as an osmotic agent that retains water in the intestinal lumen. The resulting increase in fluid volume softens stool and stimulates peristalsis, leading to rapid and complete bowel evacuation required for effective bowel preparation.

The specific dose and administration schedule of Moviprep are determined by the prescribing healthcare professional based on the patient’s age, weight, and the required procedure. Patients should follow the prescriber’s instructions exactly.

Safety of Moviprep in pregnancy or lactation has not been fully established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Moviprep, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moviprep contains polyethylene glycol with electrolytes, offering a balanced osmotic effect and generally better tolerability compared with sodium‑phosphate preparations, which may carry higher risks of electrolyte disturbances. Choice of agent depends on patient factors and physician preference.

Store Moviprep at ambient temperature, below 25 °C. Keep the container in its original packaging, protect it from moisture and direct sunlight, and ensure the seal remains intact until use.

Moviprep is taken orally as a solution. The prescribed volume is typically mixed with a specified amount of water, consumed in divided doses according to the prescriber’s instructions, followed by additional clear fluids as directed.

Serious risks include severe dehydration, significant electrolyte imbalances (such as hyponatremia or hypokalemia), and rare allergic reactions. Patients should be monitored for signs of these conditions, especially if they have underlying renal, cardiac, or metabolic disorders.

Moviprep should be avoided in individuals with known or suspected bowel obstruction, severe renal impairment, uncontrolled heart failure, or hypersensitivity to polyethylene glycol or any of its components. A healthcare professional must evaluate suitability before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT